Abstract
Objectives:
Arthroscopic superior capsule reconstruction (ASCR) has been introduced as an alternative to latissimus dorsi transfer (LDT) for the treatment of irreparable rotator cuff tears in young patients. The hypothesis of this study is that preliminary clinical outcomes for SCR patients will not significantly differ from those of LDT patients for irreparable and massive rotator cuff tears.
Methods:
Patients who underwent either a LDT or an ASCR and were a minimum of 6 months (mean, 12 months) out from surgery were included. In the SCR technique, a 3-mm acellular human dermal allograft was customized to the exact size of the defect. Surgical, objective, and demographic data were prospectively collected and retrospectively reviewed. Patient-reported outcome (PRO) measures included ASES, SANE, QuickDASH, SF-12 and satisfaction scores. Acromiohumeral distance (AHD) was measured and Hamada classification applied. Patients progressing to reverse shoulder arthroplasty (rTSA) or patients with a graft disruption were considered failures.
Results:
34 patients (13 women, 21 men) with a mean age of 52
Conclusion:
Patients who underwent ASCR had significantly improved clinical scores and improved range of motion compared to patients who underwent LDT, but longer follow-up is needed.
